Eli Lilly’s growth hinges on surging demand for its diabetes and weight-loss medicines, with supply expansion and better insurance coverage helping more patients access them. The big question is whether high prices, side effects, and new rivals can slow momentum before Lilly’s manufacturing catch-up pays off.Read more